1
|
Kootiratrakarn T, Kampirapap K and
Chunhasewee C: Epidermal permeability barrier in the treatment of
keratosis pilaris. Dermatol Res Pract. 2015:2050122015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ehsani A, Namazi MR, Barikbin B and Nazemi
MJ: Unilaterally generalized keratosis pilaris. J Eur Acad Dermatol
Venereol. 17:361–362. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gruber R, Sugarman JL, Crumrine D, Hupe M,
Mauro TM, Mauldin EA, Thyssen JP, Brandner JM, Hennies H, Schmuth M
and Elias PM: Sebaceous gland, hair shaft, and epidermal barrier
abnormalities in keratosis pilaris with and without filaggrin
deficiency. Am J Pathol. 185:1012–1021. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Poskitt L and Wilkinson JD: Natural
history of keratosis pilaris. Br J Dermatol. 130:711–713. 1994.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Park KY, Son IP, Choi SY, Seo SJ and Hong
CK: Combination peel with incorporated fractional prickle coral
calcium for the treatment of keratosis pilaris: A pilot study. J
Dermatolog Treat. 25:314–318. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Thai K and Sinclair RD: Keratosis pilaris
and hereditary koilonychia without monilethrix. J Am Acad Dermatol.
45:627–629. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Nazarenko SA, Ostroverkhova NV, Vasiljeva
EO, Nazarenko LP, Puzyrev VP, Malet P and Nemtseva TA: Keratosis
pilaris and ulerythema ophryogenes associated with an 18p deletion
caused by a Y/18 translocation. Am J Med Genet. 85:179–182. 1999.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Brown SJ, Relton CL, Liao H, Zhao Y,
Sandilands A, McLean WH, Cordell HJ and Reynolds NJ: Filaggrin
haploinsufficiency is highly penetrant and is associated with
increased severity of eczema: Further delineation of the skin
phenotype in a prospective epidemiological study of 792 school
children. Br J Dermatol. 161:884–889. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mevorah B, Marazzi A and Frenk E: The
prevalence of accentuated palmoplantar markings and keratosis
pilaris in atopic dermatitis, autosomal dominant ichthyosis and
control dermatological patients. Br J Dermatol. 112:679–685. 1985.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Sandilands A, O'Regan GM, Liao H, Zhao Y,
Terron-Kwiatkowski A, Watson RM, Cassidy AJ, Goudie DR, Smith FJ,
McLean WH and Irvine AD: Prevalent and rare mutations in the gene
encoding filaggrin cause ichthyosis vulgaris and predispose
individuals to atopic dermatitis. J Invest Dermatol. 126:1770–1775.
2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Tchernev G, Ananiev J, Semkova K,
Dourmishev LA, Schonlebe J and Wollina U: Nevus comedonicus: An
updated review. Dermatol Ther (Heidelb). 3:33–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Levinsohn JL, Sugarman JL, McNiff JM,
Antaya RJ and Choate KA: Somatic mutations in NEK9 cause nevus
comedonicus. Am J Hum Genet. 98:1030–1037. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Mahajan RS, Shah MM, Ninama KR and
Bilimoria FE: Extensive nevus comedonicus. Indian Dermatol Online
J. 5:520–521. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ito T, Mitamura Y, Tsuji Y, Harada K and
Urabe K: Bilateral nevus comedonicus syndrome. Yonago Acta Med.
56:59–61. 2013.PubMed/NCBI
|
15
|
Beck MH and Dave VK: Extensive nevus
comedonicus. Arch Dermatol. 116:1048–1050. 1980. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lee D, Yamasaki K, Rudsil J, Zouboulis CC,
Park GT, Yang J and Gallo RL: Sebocytes express functional
cathelicidin antimicrobial peptides and can act to kill
propionibacterium acnes. J Invest Dermatol. 128:1863–1866. 2008.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Brown SJ, Relton CL, Liao H, Zhao Y,
Sandilands A, Wilson IJ, Burn J, Reynolds NJ, McLean WH and Cordell
HJ: Filaggrin null mutations and childhood atopic eczema: A
population-based case-control study. J Allergy Clin Immunol.
121:940–946. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Thomas AC, Cullup T, Norgett EE, Hill T,
Barton S, Dale BA, Sprecher E, Sheridan E, Taylor AE, Wilroy RS, et
al: ABCA12 is the major harlequin ichthyosis gene. J Invest
Dermatol. 126:2408–2413. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Akiyama M: ABCA12 mutations and autosomal
recessive congenital ichthyosis: A review of genotype/phenotype
correlations and of pathogenetic concepts. Hum Mutat. 31:1090–1096.
2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Annilo T, Shulenin S, Chen ZQ, Arnould I,
Prades C, Lemoine C, Maintoux-Larois C, Devaud C, Dean M, Denefle P
and Rosier M: Identification and characterization of a novel ABCA
subfamily member, ABCA12, located in the lamellar ichthyosis region
on 2q34. Cytogenet Genome Res. 98:169–176. 2002. View Article : Google Scholar : PubMed/NCBI
|
21
|
Lefevre C, Audebert S, Jobard F, Bouadjar
B, Lakhdar H, Boughdene-Stambouli O, Blanchet-Bardon C, Heilig R,
Foglio M, Weissenbach J, et al: Mutations in the transporter ABCA12
are associated with lamellar ichthyosis type 2. Hum Mol Genet.
12:2369–2378. 2003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Akiyama M, Sugiyama-Nakagiri Y, Sakai K,
McMillan JR, Goto M, Arita K, Tsuji-Abe Y, Tabata N, Matsuoka K,
Sasaki R, et al: Mutations in lipid transporter ABCA12 in harlequin
ichthyosis and functional recovery by corrective gene transfer. J
Clin Invest. 115:1777–1784. 2005. View
Article : Google Scholar : PubMed/NCBI
|
23
|
Wang XQ, Sun P and Paller AS: Inhibition
of integrin-linked kinase/protein kinase B/Akt signaling: mechanism
for ganglioside-induced apoptosis. J Biol Chem. 276:44504–44511.
2001. View Article : Google Scholar : PubMed/NCBI
|
24
|
Sun P, Wang XQ, Lopatka K, Bangash S and
Paller AS: Ganglioside loss promotes survival primarily by
activating integrin-linked kinase/Akt without phosphoinositide 3-OH
kinase signaling. J Invest Dermatol. 119:107–117. 2002. View Article : Google Scholar : PubMed/NCBI
|
25
|
Jiang YJ, Uchida Y, Lu B, Kim P, Mao C,
Akiyama M, Elias PM, Holleran WM, Grunfeld C and Feingold KR:
Ceramide stimulates ABCA12 expression via peroxisome
proliferator-activated receptor in human keratinocytes. J Biol
Chem. 284:18942–18952. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zuo Y, Zhuang DZ, Han R, Isaac G, Tobin
JJ, McKee M, Welti R, Brissette JL, Fitzgerald ML and Freeman MW:
ABCA12 maintains the epidermal lipid permeability barrier by
facilitating formation of ceramide linoleic esters. J Biol Chem.
283:36624–36635. 2008. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kurokawa I, Nakai Y, Nishimura K, Hakamada
A, Isoda K, Yamanaka K, Mizutani H and Tsubura A: Cytokeratin and
filaggrin expression in nevus comedonicus. J Cutan Pathol.
34:338–341. 2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
Yamanaka Y, Akiyama M, Sugiyama-Nakagiri
Y, Sakai K, Goto M, McMillan JR, Ota M, Sawamura D and Shimizu H:
Expression of the keratinocyte lipid transporter ABCA12 in
developing and reconstituted human epidermis. Am J Pathol.
171:43–52. 2007. View Article : Google Scholar : PubMed/NCBI
|